Literature DB >> 3706713

Separation and quantitation of metallothioneins by high-performance liquid chromatography coupled with atomic absorption spectrophotometry.

L D Lehman, C D Klaassen.   

Abstract

A rapid, reproducible, and sensitive high-performance liquid chromatography (HPLC) method for the determination of the concentrations of metallothionein-I (MT-I) and metallothionein-II (MT-II) in rat liver has been developed. Metallothioneins (MTs) were separated and quantitated by anion-exchange high-performance liquid chromatography coupled with atomic absorption spectrophotometry (AAS). Purified rat liver MT-I and MT-II, used as standards for developing the method, were easily resolved, eluting at 7.5 and 10.4 min, respectively. To establish standard curves, protein concentrations of solutions of the purified MTs were determined by the Kjeldahl method for the determination of nitrogen, after which the standards were saturated with Cd (final concentration of 50 ppm Cd). Rat liver cytosols obtained from untreated and Cd- or Zn-treated rats were prepared for HPLC-AAS analysis by saturation with Cd (50 ppm Cd) followed by heat denaturation (placing in a boiling water bath for 1 min). Based on the method of standard additions, recovery of MTs exceeded 95% and repeated injection of a sample yielded a coefficient of variance of approximately 2%. A detection limit of 5 micrograms MT/g liver was established for the method. Only MT-II was detected in untreated rats, whereas following exposure to Cd or Zn, both forms of MTs were detected. Concentrations of total MTs in liver of untreated and Cd- or Zn-treated rats were also determined by the Cd/hemoglobin radioassay (which fails to distinguish MT-I from MT-II) and indicated that results obtained with the HPLC-AAS method compared favorably to the Cd/hemoglobin radioassay. Thus, the HPLC-AAS method for quantitating MT-I and MT-II offers the advantage of determining the concentrations of both proteins in tissues and should be useful for studying the regulation of MT-I and MT-II.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706713     DOI: 10.1016/0003-2697(86)90097-7

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  Induction of hepatic metallothioneins determined at isoprotein and messenger RNA levels in glucocorticoid-treated rats.

Authors:  L D Lehman-McKeeman; G K Andrews; C D Klaassen
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

2.  Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis.

Authors:  John C Barbato; Otilia Catanescu; Kelsey Murray; Patricia M DiBello; Donald W Jacobsen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-02       Impact factor: 8.311

3.  Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering.

Authors:  J Xiang; J Koropatnick; Y Qi; X Luo; T Moyana; K Li; Y Chen
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

4.  Influence of thyroparathyroidectomy and thyroxine replacement on Cu and Zn cellular distribution and on the metallothionein level and induction in rats.

Authors:  G Leblondel; A Le Bouil; P Allain
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

5.  Regulation of the isoforms of metallothionein.

Authors:  C D Klaassen; L D Lehman-McKeeman
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

6.  In vitro and in vivo studies on the degradation of metallothionein.

Authors:  C D Klaassen; S Choudhuri; J M McKim; L D Lehman-McKeeman; W C Kershaw
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.